Daiichi Sankyo Company LTD
$4.6M 51 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Biotronik Inc.
Biotronik Inc. reported $4,534,235.77 across General Payments, Research, and Ownership to 10,399 physicians and teaching hospitals across 15,086 transactions.
- $4.5M
- All-tracks total
- 15,086
- Transactions
- 10,399
- Recipients
- −$589.3K
- General Payments vs PY2023
Biotronik Inc. reported $4,534,235.77 across all CMS Open Payments tracks (General + Research + Ownership) to 10,399 physicians and teaching hospitals in Program Year 2024 - ranking #289 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,441,764.53, averaging $436.03 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer biotronik-inc Biotronik Inc.
$4.5M · #289/1,925 · 0.0% industry · PY2024
- TOT $4.5M
- RANK #289
- SHARE 0.0%
- TXN 15,086
- RCP 10,399
- CAT 9
- GEN $2.4M
- ΔGEN −$589.3K
- TOP1 6.0%
- PY 2024
Volume peers
Nearest volume peer: Daiichi Sankyo Company LTD ($4.6M)
Biotronik Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Biotronik Inc.'s CMS-reported General Payments decreased by $589.3K (−19.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BIOTRONIK INC.PY2023: BIOTRONIK INC.PY2024: BIOTRONIK INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $3,031,079.68
- PY2024
- $2,441,764.53
What the Data Shows for Biotronik Inc.
Averaging $300.56 per transaction and $436.03 per recipient, Biotronik Inc.'s Program Year 2024 total comes to $4,534,235.77 across 15,086 transactions and 10,399 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #289 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 9-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Debt Forgiveness" at $898.4K, accounting for 36.8% of this company's General Payments and 272 transactions.
General Payment Breakdown by Type
Biotronik Inc. made 9 types of general payments. "Debt Forgiveness" is the largest category at $898.4K, 36.8% of General Payments.
Biotronik Inc. reports 9 general-payment categories - the top three are Debt Forgiveness (36.8%), Food and Beverage (19.7%), and Travel and Lodging (17.4%). The remaining 6 categories make up 26.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Biotronik Inc. files across 9 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Biotronik Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Debt Forgiveness | $898.4K | 272 | 36.8% |
| Food and Beverage | $481.2K | 8,924 | 19.7% |
| Travel and Lodging | $424.1K | 823 | 17.4% |
| Compensation for Faculty or Speaker (Medical Education) | $231.1K | 87 | 9.5% |
| Consulting Fee | $203.9K | 88 | 8.4% |
| Grant | $143.0K | 15 | 5.9% |
| Space Rental or Facility Fees | $49.5K | 10 | 2.0% |
| Education | $7.5K | 179 | 0.3% |
| Charitable Contribution | $3.0K | 1 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $380,725.14 (15.6%) of $2,441,764.53 in this company's General Payments records across 2,902 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Biotronik Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Bayonne Medical Center
$147,601.05 across 24 reported transactions
- 2
Ron Waksman
$118,497.87 across 10 reported transactions
- 3
Scripps Green Hospital
$40,921.07 across 17 reported transactions
- 4
Gaurav Upadhyay
$38,705.15 across 7 reported transactions
- 5
Washington Hospital Center
$35,000.00 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Biotronik Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Biotronik Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Biotronik Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
bluebird bio, Inc.
$4.5M 229 recipients
Compare payment profiles
Ipsen Pharma SAS
$4.6M 54 recipients
Compare payment profiles
Novocure Inc.
$4.5M 3,615 recipients
Compare payment profiles
Octapharma USA, Inc.
$4.4M 5,207 recipients
Compare payment profiles
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$4.4M 161,040 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.